Chinese Patent Drug Manufacturing in China - Industry Market Research Report
Chinese Patent Drug Manufacturing in China
Skepticism about the effectiveness of Western medicine in China has led to the rising popularity of Chinese patent medicine, which is considered to be less toxic and have fewer side effects. Increasingly, patients are choosing traditional Chinese medicine as their primary treatment. Additionally, the aging population and increasing health consciousness are factors contributing to industry demand. Along with the implementation of the Healthy China strategy, reforms in the medical and healthcare system have continued to deepen.
The Chinese Patent Drug Manufacturing industry in China processes Chinese herbs to produce traditional Chinese patent medicine in capsule, powder, and liquid forms. Chinese traditional medicine pills are not manufactured by this industry (see IBISWorld industry report 2730).
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
TABLE OF CONTENTS
ABOUT THIS INDUSTRY
Industry Definition Main Activities Similar Industries Additional Resources
INDUSTRY PERFORMANCE
Executive Summary Key External Drivers Current Performance Industry Outlook Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain Products & Services Demand Determinants Major Markets International Trade Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration Key Success Factors Cost Structure Benchmarks Basis of Competition Barriers to Entry Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity Technology & Systems Revenue Volatility Regulation & Policy Industry Assistance